|
PTMA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.645190E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.266000E-01 |
| Normal-vs-Stage2 |
9.886000E-01 |
| Normal-vs-Stage3 |
2.084400E-01 |
| Normal-vs-Stage4 |
3.276200E-02 |
| Stage1-vs-Stage2 |
3.118400E-01 |
| Stage1-vs-Stage3 |
9.281400E-01 |
| Stage1-vs-Stage4 |
2.579400E-01 |
| Stage2-vs-Stage3 |
3.011200E-01 |
| Stage2-vs-Stage4 |
7.636300E-02 |
| Stage3-vs-Stage4 |
2.753000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.612100E-02 |
| Normal-vs-AfricanAmerican |
3.752400E-01 |
| Normal-vs-Asian |
4.625800E-01 |
| Caucasian-vs-AfricanAmerican |
4.574000E-01 |
| Caucasian-vs-Asian |
9.305200E-01 |
| AfricanAmerican-vs-Asian |
8.481000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.632180E-01 |
| Normal-vs-Female |
1.194380E-01 |
| Male-vs-Female |
6.690200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.156400E-01 |
| Normal-vs-Extreme_Weight |
1.146220E-01 |
| Normal-vs-Obese |
9.823600E-02 |
| Normal-vs-Extreme_Obese |
1.551430E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.035800E-01 |
| Normal_Weight-vs-Obese |
5.648600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.676060E-02 |
| Extreme_Weight-vs-Obese |
9.306600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.201600E-03 |
| Obese-vs-Extreme_Obese |
2.601900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.401500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.786200E-02 |
| Normal-vs-Age(61-80Yrs) |
4.190600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.526800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.679200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.012400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.061650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.482500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.896000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.561800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.978500E-03 |
| Normal-VS-Type2 PRCC |
3.422600E-03 |
| Normal-VS-KIRP CIMP |
7.326300E-02 |
| Normal-VS-Unclassified PRCC |
2.907000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
<1E-12 |
| Type1 PRCC-VS-KIRP CIMP |
9.878000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.029190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.87899999999753E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
6.819300E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
4.096000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.869400E-01 |
| Normal-vs-N1 |
4.232300E-02 |
| Normal-vs-N2 |
1.870430E-01 |
| N0-vs-N1 |
3.092300E-02 |
| N0-vs-N2 |
1.948190E-01 |
| N1-vs-N2 |
8.232800E-01 |
|
|
